Literature DB >> 8476771

Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors.

M J Reed1, L Topping, N G Coldham, A Purohit, M W Ghilchik, V H James.   

Abstract

The aromatase complex has a key role in regulating oestrogen formation in normal and malignant breast tissues. Using dexamethasone-treated fibroblasts, derived from breast tumours, breast tumour cytosol and breast tumour-derived conditioned medium (CM) markedly stimulate aromatase activity. The cytokine, interleukin-6 (IL-6) has been identified as a factor present in CM which is capable of stimulating aromatase activity. To examine whether IL-6 may have a role in vivo in regulating breast tissue aromatase activity, IL-6 production and aromatase activity in breast tumour and adipose tissue from breast quadrants were examined. In 5/6 breasts examined so far, aromatase activity was highest in adipose tissue in the breast quadrant containing the tumour or on which the tumour impinged. There was a significant correlation (P < 0.05, Kendall's rank correlation) between IL-6 production and aromatase activity in these breast tissues. It is concluded that IL-6 may have an important role in regulating aromatase activity in breast tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476771     DOI: 10.1016/0960-0760(93)90264-w

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  16 in total

Review 1.  Aromatase, breast cancer and obesity: a complex interaction.

Authors:  Serdar E Bulun; Dong Chen; Irene Moy; David C Brooks; Hong Zhao
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

2.  Low density lipoproteins and Lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro.

Authors:  N Mehta; J Hordines; D Sykes; R J Doerr; S A Cohen
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

Review 3.  Aromatase inhibitors and inactivators for breast cancer therapy.

Authors:  Per E Lønning
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Adverse life events and breast cancer. Association may be due to imbalance in ratio of adrenal androgens to glucocorticoid.

Authors:  M J Reed; M W Ghilchik
Journal:  BMJ       Date:  1996-03-30

Review 5.  Chemoprevention of breast cancer: implications for postmenopausal women.

Authors:  Carol J Fabian; Bruce F Kimler
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  Central Administration of Indomethacin Mitigates the Injury-Induced Upregulation of Aromatase Expression and Estradiol Content in the Zebra Finch Brain.

Authors:  Alyssa L Pedersen; Jenna L Brownrout; Colin J Saldanha
Journal:  Endocrinology       Date:  2017-08-01       Impact factor: 4.736

Review 7.  Biology of aromatase in the mammary gland.

Authors:  E R Simpson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

8.  Aromatase excess in cancers of breast, endometrium and ovary.

Authors:  Serdar E Bulun; Dong Chen; Meiling Lu; Hong Zhao; Youhong Cheng; Masashi Demura; Bertan Yilmaz; Regina Martin; Hiroki Utsunomiya; Steven Thung; Emily Su; Erica Marsh; Amy Hakim; Ping Yin; Hiroshi Ishikawa; Sanober Amin; Gonca Imir; Bilgin Gurates; Erkut Attar; Scott Reierstad; Joy Innes; Zhihong Lin
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

Review 9.  The role of aromatase in breast tumors.

Authors:  M J Reed
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Aromatase and COX in breast cancer: enzyme inhibitors and beyond.

Authors:  Robert W Brueggemeier; Bin Su; Yasuro Sugimoto; Edgar S Díaz-Cruz; Danyetta D Davis
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-25       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.